You have 9 free searches left this month | for more free features.

bromfenac

Showing 1 - 25 of 67

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pain, Intravitreal Injection, Pain, Acute Trial in Canada, United States (Use of bromfenac 0.09% to reduce intravitreal

Recruiting
  • Pain
  • +2 more
  • Use of bromfenac 0.09% to reduce intravitreal injection pain
  • Use of artificial tears to reduce intravitreal injection pain
  • Boston, Massachusetts
  • +4 more
Nov 8, 2023

Diabetic Macular Edema Trial (laser photocoagulation, eye drop bromfenac 0.09%, Placebo)

Completed
  • Diabetic Macular Edema
  • laser photocoagulation
  • +2 more
  • (no location specified)
Feb 10, 2023

Familial Exudative Vitreoretinopathies Trial (Bromfenac Sodium)

Not yet recruiting
  • Familial Exudative Vitreoretinopathies
  • Bromfenac Sodium
  • (no location specified)
Oct 23, 2021

Cystoid Macular Edema Following Cataract Surgery Trial in Zagreb (Bromfenac Ophthalmic 0.09% Ophthalmic Solution, Dexamethasone

Completed
  • Cystoid Macular Edema Following Cataract Surgery
  • Bromfenac Ophthalmic 0.09% Ophthalmic Solution
  • +3 more
  • Zagreb, Grad Zagreb, Croatia
    KBCZagreb
May 15, 2022

Cataract Trial (ISV-303, Bromday™)

Completed
  • Cataract
  • (no location specified)
Nov 18, 2021

Presbyopia Trial in Mexico City (Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac, Pilocarpine

Recruiting
  • Presbyopia
  • Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac
  • +2 more
  • Mexico City, Mexico
    Optall Vision
Aug 14, 2021

Cataract Trial in Mount Pleasant (Pred-Gati-Brom, Prednisolone acetate 1% ophthalmic suspension, Gatifloxacin Ophthalmic)

Completed
  • Cataract
  • Mount Pleasant, South Carolina
    Carolina Eyecare Physicians, LLC
Jun 9, 2022

Dry Eye Disease Trial (ISV 101)

Withdrawn
  • Dry Eye Disease
  • ISV 101
  • (no location specified)
Nov 18, 2021

Presbyopia Trial in Mexico City (Pilocarpine, brimonidine, oxymetazoline, hyaluronic acid, bromfenac (PBOHB) compound)

Recruiting
  • Presbyopia
  • Pilocarpine, brimonidine, oxymetazoline, hyaluronic acid, bromfenac (PBOHB) compound
  • Mexico City, Mexico
    Optall Vision
Aug 14, 2021

Ocular Inflammation Trial (ISV-303, DuraSite Vehicle, Xibrom™)

Completed
  • Ocular Inflammation
  • (no location specified)
Nov 18, 2021

Inflammation, Pseudophakia Trial (Bromfenac, Nepafenac)

Completed
  • Inflammation
  • Pseudophakia
  • (no location specified)
Oct 8, 2020

Dry Eye Syndrome Trial in Irvine (Bromfenac Ophthalmic Solution A, Bromfenac Ophthalmic Solution B, Placebo Comparator)

Completed
  • Dry Eye Syndrome
  • Bromfenac Ophthalmic Solution A
  • +2 more
  • Irvine, California
    ISTA Pharmaceuticals, Inc.
Sep 2, 2020

Glaucoma Trial (Bromfenac 0.07% Oph Susp, Dexamethasone)

Not yet recruiting
  • Glaucoma
  • (no location specified)
Oct 15, 2020

Macular Edema, Cystoid Macular Edema, Retinal Disease Trial in Worldwide (Bromfenac, Dexamethasone, Triamcinolone Acetonide)

Recruiting
  • Macular Edema
  • +5 more
  • Bromfenac
  • +3 more
  • Vienna, Austria
  • +9 more
Dec 2, 2021

Dry Eye Disease Trial in Irvine (bromfenac ophthalmic solution 0.06%)

Completed
  • Dry Eye Disease
  • bromfenac ophthalmic solution 0.06%
  • Irvine, California
    ISTA Pharmaceuticals, Inc.
Aug 25, 2020

Intravitreal Injections, IVI Trial in Madison (Bromfenac, Artificial tears)

Completed
  • Intravitreal Injections
  • IVI
  • Bromfenac
  • Artificial tears
  • Madison, Wisconsin
    University of Wisconsin
Sep 24, 2020

Pterygium, Pain Trial in Guangzhou (0.1% bromfenac)

Completed
  • Pterygium
  • Pain
  • 0.1% bromfenac
  • Guangzhou, Guangdong, China
  • +1 more
Jul 13, 2019

Inflammation Eye Trial in Reggio Emilia (Bromfenac 0.09 % Ophthalmic Solution, Dexamethasone 0.1% ophthalmic suspension)

Completed
  • Inflammation Eye
  • Bromfenac 0.09 % Ophthalmic Solution
  • Dexamethasone 0.1% ophthalmic suspension
  • Reggio Emilia, RE, Italy
    Arcispedale Santa Maria Nuova IRCSS - Ophthalmology
May 31, 2019

Pterygium, Ocular Pain, Ocular Inflammation Trial in Guadalajara, Ciudad de México (PRO-155, Placebo)

Completed
  • Pterygium
  • +3 more
  • Guadalajara, Jalisco, Mexico
  • +2 more
Oct 30, 2019

Inflammation, Cataract Trial in Guadalajara (Bromfenac)

Completed
  • Inflammation
  • Cataract
  • Bromfenac
  • Guadalajara, Jalisco, Mexico
    Unidad Medica "Grupo Pediátrico"
Oct 2, 2019

Cataract Trial in Ciudad de Mexico (0,09% Bromfenac, 0,1% sodium hyaluronate)

Unknown status
  • Cataract
  • 0,09% Bromfenac
  • 0,1% sodium hyaluronate
  • Ciudad de Mexico, Mexico
    Maria Camila Aguilar Sierra
Feb 4, 2019

Treatment of Ocular Inflammation Associated With Cataract Surgery Trial (Bromfenac, Nepafenac)

Completed
  • Treatment of Ocular Inflammation Associated With Cataract Surgery
  • (no location specified)
Mar 28, 2019

Ocular Inflammation Trial (ISV-303, DuraSite Vehicle)

Completed
  • Ocular Inflammation
  • (no location specified)
Nov 18, 2021

Ocular Inflammation Trial (ISV-303, DuraSite Vehicle)

Completed
  • Ocular Inflammation
  • (no location specified)
Nov 18, 2021

Cataract, Retinal Edema, Inflammation Trial in Nashville (Prolensa (bromfenac 0.07%), Ilevro (nepafenac 0.3%))

Completed
  • Cataract
  • +2 more
  • Prolensa (bromfenac 0.07%)
  • Ilevro (nepafenac 0.3%)
  • Nashville, Tennessee
    Toyos Clinic
Oct 14, 2018